Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25306868
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Arthritis+Rheumatol
2014 ; 66
(12
): 3359-70
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Vimentin is a dominant target of in situ humoral immunity in human lupus
tubulointerstitial nephritis
#MMPMID25306868
Kinloch AJ
; Chang A
; Ko K
; Henry Dunand CJ
; Henderson S
; Maienschein-Cline M
; Kaverina N
; Rovin BH
; Salgado Ferrer M
; Wolfgeher D
; Liarski V
; Haddon DJ
; Utz PJ
; Wilson PC
; Clark MR
Arthritis Rheumatol
2014[Dec]; 66
(12
): 3359-70
PMID25306868
show ga
OBJECTIVE: In lupus nephritis (LN), severe tubulointerstitial inflammation (TII)
predicts progression to renal failure. Severe TII is associated with tertiary
lymphoid neogenesis and in situ antigen-driven clonal B cell selection. The
autoantigen(s) driving in situ B cell selection in TII are not known. This study
was undertaken to identify the dominant driving autoantigen(s). METHODS: Single
CD38+ or Ki-67+ B cells were laser captured from 7 biopsy specimens that were
diagnostic for LN. Eighteen clonally expanded immunoglobulin heavy- and
light-chain variable region pairs were cloned and expressed as monoclonal
antibodies. Seven more antibodies were cloned from flow-sorted CD38+ cells from
an eighth biopsy specimen. Antigen characterization was performed using a
combination of confocal microscopy, enzyme-linked immunosorbent assay, screening
protoarrays, immunoprecipitation, and mass spectrometry. Serum IgG titers to the
dominant antigen in 48 LN and 35 non-nephritic lupus samples were determined
using purified antigen-coated arrays. Autoantigen expression on normal and LN
kidney was localized by immunohistochemistry and immunofluorescence. RESULTS:
Eleven of 25 antibodies reacted with cytoplasmic structures, 4 reacted with
nuclei, and none reacted with double-stranded DNA. Vimentin was the only
autoantigen identified by both mass spectrometry and protoarray. Ten of the 11
anticytoplasmic TII antibodies directly bound vimentin. Vimentin was highly
expressed by tubulointerstitial inflammatory cells, and the TII antibodies tested
preferentially bound inflamed tubulointerstitium. Finally, high titers of serum
antivimentin antibodies were associated with severe TII (P = 0.0001). CONCLUSION:
Vimentin, an antigenic feature of inflammation, is a dominant autoantigen
targeted in situ in LN TII. This adaptive autoimmune response likely feeds
forward to worsen TII and renal damage.